Thank you, Mr. Chair.
Thank you to both of our witnesses for an excellent time together so far.
Dr. Mihailidis, you mentioned in your three recommendations that there was a 16% decline in R and D investment in Canada. What are the structural issues leading to such a decline and what can we do to improve it?